Logo image of ICAD.PA

ICADE (ICAD.PA) Stock Fundamental Analysis

EPA:ICAD - Euronext Paris - Matif - FR0000035081 - REIT - Currency: EUR

20.66  0 (0%)

Fundamental Rating

4

ICAD gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 42 industry peers in the Diversified REITs industry. ICAD may be in some trouble as it scores bad on both profitability and health. A decent growth rate in combination with a cheap valuation! Better keep an eye on ICAD.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ICAD had positive earnings in the past year.
ICAD had a positive operating cash flow in the past year.
In multiple years ICAD reported negative net income over the last 5 years.
ICAD had a positive operating cash flow in each of the past 5 years.
ICAD.PA Yearly Net Income VS EBIT VS OCF VS FCFICAD.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

ICAD has a Return On Assets of -4.34%. This is amonst the worse of the industry: ICAD underperforms 80.49% of its industry peers.
The Return On Equity of ICAD (-10.56%) is worse than 80.49% of its industry peers.
With a Return On Invested Capital value of 2.23%, ICAD is not doing good in the industry: 82.93% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -4.34%
ROE -10.56%
ROIC 2.23%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ICAD.PA Yearly ROA, ROE, ROICICAD.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

The Operating Margin of ICAD (11.72%) is worse than 85.37% of its industry peers.
In the last couple of years the Operating Margin of ICAD has declined.
The Profit Margin and Gross Margin are not available for ICAD so they could not be analyzed.
Industry RankSector Rank
OM 11.72%
PM (TTM) N/A
GM N/A
OM growth 3Y-28.18%
OM growth 5Y-3.81%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ICAD.PA Yearly Profit, Operating, Gross MarginsICAD.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ICAD is destroying value.
ICAD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ICAD.PA Yearly Shares OutstandingICAD.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
ICAD.PA Yearly Total Debt VS Total AssetsICAD.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

2.2 Solvency

ICAD has an Altman-Z score of 0.90. This is a bad value and indicates that ICAD is not financially healthy and even has some risk of bankruptcy.
ICAD has a Altman-Z score of 0.90. This is comparable to the rest of the industry: ICAD outperforms 48.78% of its industry peers.
The Debt to FCF ratio of ICAD is 28.49, which is on the high side as it means it would take ICAD, 28.49 years of fcf income to pay off all of its debts.
ICAD has a worse Debt to FCF ratio (28.49) than 70.73% of its industry peers.
A Debt/Equity ratio of 0.99 indicates that ICAD is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.99, ICAD is doing worse than 75.61% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.99
Debt/FCF 28.49
Altman-Z 0.9
ROIC/WACC0.51
WACC4.38%
ICAD.PA Yearly LT Debt VS Equity VS FCFICAD.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

ICAD has a Current Ratio of 1.84. This is a normal value and indicates that ICAD is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ICAD (1.84) is better than 92.68% of its industry peers.
A Quick Ratio of 1.55 indicates that ICAD should not have too much problems paying its short term obligations.
With an excellent Quick ratio value of 1.55, ICAD belongs to the best of the industry, outperforming 90.24% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.84
Quick Ratio 1.55
ICAD.PA Yearly Current Assets VS Current LiabilitesICAD.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 12.06% over the past year.
ICAD shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.69% yearly.
Looking at the last year, ICAD shows a very strong growth in Revenue. The Revenue has grown by 37.05%.
The Revenue has been growing slightly by 0.64% on average over the past years.
EPS 1Y (TTM)12.06%
EPS 3YN/A
EPS 5Y-9.69%
EPS Q2Q%-83.39%
Revenue 1Y (TTM)37.05%
Revenue growth 3Y-1.82%
Revenue growth 5Y0.64%
Sales Q2Q%-0.77%

3.2 Future

ICAD is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.09% yearly.
The Revenue is expected to grow by 0.13% on average over the next years.
EPS Next Y7.95%
EPS Next 2Y-1.12%
EPS Next 3Y0.09%
EPS Next 5YN/A
Revenue Next Year-2.22%
Revenue Next 2Y-1.67%
Revenue Next 3Y0.13%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ICAD.PA Yearly Revenue VS EstimatesICAD.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B
ICAD.PA Yearly EPS VS EstimatesICAD.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1 2 3 4 5

8

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 6.54, the valuation of ICAD can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of ICAD indicates a rather cheap valuation: ICAD is cheaper than 90.24% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 28.63. ICAD is valued rather cheaply when compared to this.
ICAD is valuated cheaply with a Price/Forward Earnings ratio of 6.06.
ICAD's Price/Forward Earnings ratio is rather cheap when compared to the industry. ICAD is cheaper than 95.12% of the companies in the same industry.
ICAD's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.72.
Industry RankSector Rank
PE 6.54
Fwd PE 6.06
ICAD.PA Price Earnings VS Forward Price EarningsICAD.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

87.80% of the companies in the same industry are more expensive than ICAD, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, ICAD is valued a bit cheaper than 70.73% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.48
EV/EBITDA 10.69
ICAD.PA Per share dataICAD.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

ICAD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.82
PEG (5Y)N/A
EPS Next 2Y-1.12%
EPS Next 3Y0.09%

6

5. Dividend

5.1 Amount

ICAD has a Yearly Dividend Yield of 21.25%, which is a nice return.
ICAD's Dividend Yield is rather good when compared to the industry average which is at 8.11. ICAD pays more dividend than 95.12% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.39, ICAD pays a better dividend.
Industry RankSector Rank
Dividend Yield 21.25%

5.2 History

The dividend of ICAD has a limited annual growth rate of 0.17%.
Dividend Growth(5Y)0.17%
Div Incr Years1
Div Non Decr Years1
ICAD.PA Yearly Dividends per shareICAD.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

ICAD has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of ICAD is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP-80.35%
EPS Next 2Y-1.12%
EPS Next 3Y0.09%
ICAD.PA Yearly Income VS Free CF VS DividendICAD.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B

ICADE

EPA:ICAD (3/21/2025, 7:00:00 PM)

20.66

0 (0%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-18 2025-02-18/amc
Earnings (Next)07-23 2025-07-23
Inst Owners72.42%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap1.57B
Analysts73.33
Price Target28.06 (35.82%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 21.25%
Yearly Dividend4.33
Dividend Growth(5Y)0.17%
DP-80.35%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.49%
PT rev (3m)-7.96%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-0.45%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.18%
Revenue NY rev (3m)-0.1%
Valuation
Industry RankSector Rank
PE 6.54
Fwd PE 6.06
P/S 0.69
P/FCF 9.48
P/OCF 4.3
P/B 0.36
P/tB 0.37
EV/EBITDA 10.69
EPS(TTM)3.16
EY15.3%
EPS(NY)3.41
Fwd EY16.51%
FCF(TTM)2.18
FCFY10.55%
OCF(TTM)4.81
OCFY23.26%
SpS29.79
BVpS56.72
TBVpS56.26
PEG (NY)0.82
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.34%
ROE -10.56%
ROCE 3.18%
ROIC 2.23%
ROICexc 2.72%
ROICexgc 2.73%
OM 11.72%
PM (TTM) N/A
GM N/A
FCFM 7.32%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-28.18%
OM growth 5Y-3.81%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 0.99
Debt/FCF 28.49
Debt/EBITDA 11.48
Cap/Depr 187.28%
Cap/Sales 8.82%
Interest Coverage 3.51
Cash Conversion 98.23%
Profit Quality N/A
Current Ratio 1.84
Quick Ratio 1.55
Altman-Z 0.9
F-Score7
WACC4.38%
ROIC/WACC0.51
Cap/Depr(3y)678.24%
Cap/Depr(5y)1255.8%
Cap/Sales(3y)20.42%
Cap/Sales(5y)31.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.06%
EPS 3YN/A
EPS 5Y-9.69%
EPS Q2Q%-83.39%
EPS Next Y7.95%
EPS Next 2Y-1.12%
EPS Next 3Y0.09%
EPS Next 5YN/A
Revenue 1Y (TTM)37.05%
Revenue growth 3Y-1.82%
Revenue growth 5Y0.64%
Sales Q2Q%-0.77%
Revenue Next Year-2.22%
Revenue Next 2Y-1.67%
Revenue Next 3Y0.13%
Revenue Next 5YN/A
EBIT growth 1Y3.66%
EBIT growth 3Y-29.49%
EBIT growth 5Y-3.2%
EBIT Next Year46.99%
EBIT Next 3Y15.87%
EBIT Next 5Y8.7%
FCF growth 1Y4516.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.88%
OCF growth 3Y-11.53%
OCF growth 5Y-0.14%